These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9109165)

  • 1. Potassium and magnesium retaining triamterene derivatives.
    Priewer H; Ullrich F
    Pharmazie; 1997 Mar; 52(3):179-81. PubMed ID: 9109165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium and magnesium retaining potency and efficacy of triamterene and analogues in conscious saline-loaded rats.
    Priewer H; Ullrich F; Mutschler E
    Magnes Res; 1996 Mar; 9(1):33-40. PubMed ID: 8819092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, natriuretic, antikaliuretic and antimagnesiuretic properties of an acidic triamterene derivative.
    Netzer T; Ullrich F; Majewski M; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):807-11. PubMed ID: 1418034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of conventional and potassium-sparing diuretics--aspects with relevance to Mg-sparing effects. Review of the present state of the art and recent findings.
    Heidenreich O
    Magnesium; 1984; 3(4-6):248-56. PubMed ID: 6536835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of straight-chain and branched-chain acidic triamterene derivatives.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1986 Feb; 36(2):213-5. PubMed ID: 3964327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the effects of various diuretics and aldosterone antagonists on renal magnesium excretion].
    Abdelhamid S; Seyberth H; Hänze S
    Verh Dtsch Ges Inn Med; 1969; 75():935-8. PubMed ID: 5401672
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamics of acidic triamterene derivatives and their esters and amides.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1544-7. PubMed ID: 4074412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of xipamide and triamterene - alone or in combination - on electrolyte excretion in the rat.
    Hohenegger M; Holzer F
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):298-303. PubMed ID: 965134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
    Möhrke W; Knauf H; Mutschler E
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of triamterene on serum and skeletal muscle electrolytes in diuretic-treated patients.
    Widmann L; Dyckner T; Wester PO
    Eur J Clin Pharmacol; 1988; 33(6):577-9. PubMed ID: 3366161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of electrolyte excretion by potassium retaining diuretics.
    Netzer T; Knauf H; Mutschler E
    Eur Heart J; 1992 Dec; 13 Suppl G():22-7. PubMed ID: 1486902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
    Kabakov AI; Zharov EI
    Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(11):1688-91. PubMed ID: 4091871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations on the acute toxicity of acidic and basic triamterene derivatives.
    Priewer H; Wolf E; Ullrich F; Netzer T; Vollmer G; Mutschler E
    Pharmazie; 1995 Jun; 50(6):419-21. PubMed ID: 7651980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of triamterene, aldactone and amilorid on the electrolyte excretion following oral potassium loading test in rats].
    Formanek K; Hohenegger M
    Wien Klin Wochenschr; 1970 Mar; 82(13):240-1. PubMed ID: 5419661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Animal experimental and human pharmacologic studies with phase-II metabolites of triamterene].
    Völger KD
    Arzneimittelforschung; 1991 May; 41(5):499-506. PubMed ID: 1898420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of the natriuretic and antikaliuretic properties of triamterene derivatives by dose-response experiments.
    Priewer H; Wolf E; Kraft H; Knauf H; Mutschler E
    Pharm Res; 1987 Feb; 4(1):66-9. PubMed ID: 3508532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic properties of triamterene derivatives in the coronary artery ligated rat model.
    Busch AE; Ullrich F; Mutschler E
    Arch Pharm (Weinheim); 1991 Nov; 324(11):895-8. PubMed ID: 1804067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new pteridine derivative on urinary sodium, potassium and magnesium excretion in conscious saline-loaded rats.
    Netzer T; Ullrich F; Priewer H; Majewski M; Mutschler E
    Br J Pharmacol; 1992 May; 106(1):222-6. PubMed ID: 1504728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of triamterene and of the combination of triamterene and hydrochlorothiazide on the potassium metabolic pool. Experimental studies with radioisotopes].
    Mussa GC; Pavesio D; Ballario R
    Minerva Pediatr; 1966 Sep; 18(28):1532-6. PubMed ID: 5994096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.